HilleVax logo

HilleVax Funding & Investors

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines. HilleVax was founded in 2021 and was headquartered in Boston, Massachusetts.

hillevax.com

Total Amount Raised: $235,000,000

HilleVax Funding Rounds

  • Post Ipo Equity

    $100,000,000

  • Series Unknown

    $135,000,000

    Series Unknown Investors

    Abingworth
    Franklin Resources
    Deerfield Management
    Biotechnology Value Fund
    Catalys Pacific
    Qiming Venture Partners USA
    Samsara BioCapital
    Sahsen Ventures
    Frazier Management
    Perceptive Advisors
    Lightspeed Venture Partners
    RA Capital Management
    Greenspring Associates
    Richard King Mellon Foundation
Funding info provided by Diffbot.